Aligned with current recommendations from the latest KDIGO guidelines, negative slope in Hb appeared to be associated with anemia treatment initiation, suggesting that a longitudinal decrease in Hb levels may be taken into account by clinicians when defining initiation of therapy10. The gene discussed is GSTM1; the disease is anemia.